Artwork

Content provided by Science Podcast and Science Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Science Podcast and Science Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

New treatments for deadly snake bites, and a fusion company that wants to get in the medical isotopes game

31:33
 
Share
 

Manage episode 429531678 series 31002
Content provided by Science Podcast and Science Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Science Podcast and Science Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

First up this week, Staff Writer Adrian Cho talks with host Sarah Crespi about a fusion company that isn’t aiming for net energy. Instead, it’s looking to sell off the high-energy neutrons from its fusion reactors for different purposes, such as imaging machine parts and generating medical isotopes. In the long run, the company hopes to use money from these neutron-based enterprises for bigger, more energetic reactors that may someday make fusion energy.

Next, we hear from Tian Du, a Ph.D. candidate in the Dr John and Anne Chong Lab for Functional Genomics at the University of Sydney. She talks about finding antivenom treatments by screening all the genes in the human genome. Her Science Translational Medicine paper focuses on a strong candidate for treating spitting cobra bites, but the technique may prove useful for many other venomous animal bites and stings, from jellyfish to spiders.

This week’s episode was produced with help from Podigy.

About the Science Podcast

Authors: Sarah Crespi, Adrian Cho

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

555 episodes

Artwork
iconShare
 
Manage episode 429531678 series 31002
Content provided by Science Podcast and Science Magazine. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Science Podcast and Science Magazine or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

First up this week, Staff Writer Adrian Cho talks with host Sarah Crespi about a fusion company that isn’t aiming for net energy. Instead, it’s looking to sell off the high-energy neutrons from its fusion reactors for different purposes, such as imaging machine parts and generating medical isotopes. In the long run, the company hopes to use money from these neutron-based enterprises for bigger, more energetic reactors that may someday make fusion energy.

Next, we hear from Tian Du, a Ph.D. candidate in the Dr John and Anne Chong Lab for Functional Genomics at the University of Sydney. She talks about finding antivenom treatments by screening all the genes in the human genome. Her Science Translational Medicine paper focuses on a strong candidate for treating spitting cobra bites, but the technique may prove useful for many other venomous animal bites and stings, from jellyfish to spiders.

This week’s episode was produced with help from Podigy.

About the Science Podcast

Authors: Sarah Crespi, Adrian Cho

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

555 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide